Company / Capital Expenditures
OCULAR THERAPEUTIX, INC Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$12.0M
FY2025
5-year range
$841.0K / $12.0M
FY2021-FY2025
Trend
+832.5%
vs FY2024
Sector context
#56 of 194
Health Care
What the data says
Capital Expenditures changed +832% YoY in FY2025, a notable deviation from the 9-year average annual change of +204%.
Based on SEC 10-K filings.
$12M in FY2025 with a 5-year CAGR of +39.9%.
Improved from $6M to $12M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +142.6%
- 5-Year CAGR
- +39.9%
- 10-Year CAGR
- -
Sector benchmark
#56 of 194 in Health CareTop 29% of 194This company $12.0M Sector average $117.5M
▼
-89.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +39.9%, indicating consistent growth.
- In FY2025, capital expenditures increased 832.5% year-over-year.
- Ranks #56 out of 194 companies in the Health Care sector.
- Lowest capital expenditures in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.0M | +832.5% |
| FY2024 | $1.3M | -78.8% |
| FY2023 | $6.1M | +623.8% |
| FY2022 | $841.0K | -62.4% |
| FY2021 | $2.2M | +0.0% |
| FY2020 | $2.2M | -72.9% |
| FY2019 | $8.3M | +336.8% |
| FY2018 | $1.9M | -77.1% |
| FY2017 | $8.3M | +330.0% |
| FY2016 | $1.9M | +395.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026